General Papers
ARKIVOC 2013 (iv) 88-97
CDCl3): δ 19.5. ESI-MS: m/z 499 [M+H]+, 521 [M+Na]+, 537 [M+K]. Anal. calcd for
C21H21BrFO6P: C, 50.52; H, 4.24. Found: C, 50.41; H, 4.35 %.
Diethyl 2-(4-bromophenyl)-1-(6-tert-butyl-4-oxochroman-3-yl)-2-oxoethylphosphonate (2d).
Prepared according to the general procedure. The product was obtained as white solid (71%), m
p 99-101 °C. 1H NMR (600 MHz, CDCl3): δ 7.95 (d, J 7.8 Hz, 2H), 7.74 (s, 1H), δ 7.65 (d, J
7.8 Hz, 2H), δ 7.54 (d, J 7.2 Hz, 1H), δ 6.93 (d, J 9.0 Hz, 1H), δ 5.13 (dd, J 12.0 Hz, J 6.0 Hz,
1H), δ 4.32-4.38 (m, 2H), δ 4.03-4.15 (m, 5H), δ 1.29 (t, J 7.2 Hz, 3H), δ 1.25 (t, J 7.2 Hz, 3H).
13C NMR (150 MHz, CDCl3): δ 193.5, 192.7, 159.5, 144.5, 136.1, 134.2, 130.5, 128.8, 128.2,
123.4, 119.0, 117.3, 69.6, 63.2, 47.2, 43.5, 34.3, 31.2 (d, J 142.6 Hz), 16.3. 31P NMR (243 MHz,
CDCl3): δ 13.2. ESI-MS: m/z 537 [M+H]+, 559 [M+Na]+, 575 [M+K]. Anal. calcd for
C25H30BrO6P: C, 55.88; H, 5.63. Found: C, 55.71; H, 5.57 %.
Diethyl 2-(4-bromophenyl)-1-(8-methyl-4-oxochroman-3-yl)-2-oxoethylphosphonate (2e).
Prepared according to the general procedure. The product was obtained as white solid (77%), m
p 109-110 °C. 1H NMR (600 MHz, CDCl3): δ 7.93 (d, J 8.4 Hz, 2H), δ 7.65 (d, J 8.4 Hz, 2H), δ
7.59 (d, J 8.4 Hz, 1H), δ 7.34 (d, J 7.2 Hz, 1H), δ 6.88 (t, J 7.8 Hz, 1H), δ 5.20 (dd, J 11.4 Hz, J
5.4 Hz, 1H), δ 4.36-4.41 (m, 2H), δ 4.04-4.17 (m, 5H), δ 1.29 (t, J 7.2 Hz, 3H), δ 1.19 (t, J 7.2
Hz, 3H). 13C NMR (150 MHz, CDCl3): δ 193.5, 192.4, 159.8, 137.2, 136.1, 131.8, 130.3, 128.2,
127.0, 124.9, 120.9, 119.4, 63.2, 46.9, 44.3, 43.5, 16.2, 15.5. 31P NMR (243 MHz, CDCl3): δ
15.1. ESI-MS: m/z 495 [M+H]+, 517 [M+Na]+, 533 [M+K]. Anal. calcd for C22H24BrO6P: C,
53.35; H, 4.88. Found: C, 53.19; H, 4.64 %.
Diethyl 2-(4-bromophenyl)-1-(6,8-di-tert-butyl-4-oxochroman-3-yl)-2-oxoethylphosphonate
(2f). Prepared according to the general procedure. The product was obtained as white solid
1
(69%), mp 114-116 °C. H NMR (600 MHz, CDCl3): δ 7.93 (d, J 8.4 Hz, 2H), δ 7.65 (d, J 8.4
Hz, 2H), δ 7.63 (s, 1H), δ 7.53 (s, 1H), δ 5.19 (dd, J 11.4 Hz, J 5.4 Hz, 1H), δ 4.31-4.35 (m, 2H),
δ 4.04-4.16 (m, 5H), δ 1.40 (s, 9H), δ 1.26 (t, J 7.2 Hz, 3H), δ 1.23 (s, 9H), δ 1.17 (t, J 7.2 Hz,
3H). 13C NMR (150 MHz, CDCl3): δ 193.5, 183.8, 158.7, 143.4, 138.2, 136.2, 131.8, 131.1,
31
130.3, 128.1, 121.4, 119.7, 63.2 (d, J 30 Hz), 47.0, 44.4, 43.5, 35.0, 34.4, 31.2, 29.6, 16.2. P
NMR (243 MHz, CDCl3): δ 12.6. ESI-MS: m/z 593 [M+H]+, 615 [M+Na]+, 631 [M+K]. Anal.
calcd for C29H38BrO6P: C, 58.69; H, 6.45. Found: C, 58.82; H, 6.51 %.
Synthesis of diethyl [2-(4-chlorophenyl)-1,4-dihydro-chromeno[4,3-b]pyrrole-3- phosphonate
(4): To an oven-dried round-bottom flask equipped with a magnetic bar was added 1a (296 mg,
1.0 mmol, 1.0 equiv), pre-catalyst 3a (18 mg, 0.05 mmol, 0.05 equiv), 4-chlorobenzaldehyde
(140 mg, 1.0 mmol, 1.0 equiv), anhydrous THF (2 ml), and dry K2CO3 ( 14 mg, 0.1 mmol, 0.10
equiv.) under a N2 or Ar atmosphere at r.t. The resulting mixture was then stirred for 3 h at
15-17 °C. The progress of the reaction was monitored by TLC. NH4OAc (231 mg, 3 mmol) and
gacial AcOH (3 ml) were added under N2 atmosphere, the mixture was allowed to be stirred
under reflux for 12 h. Upon completion, the mixture was cooled to r.t. The workup involved
addition of ice water (20 ml) and extraction of the product mixture into CHCl3 (3 × 20 ml),
washing with sat. aq. NaHCO3 and sat. brine. After phase separation, drying over Na2SO4,
filtration and evaporation, the crude product was purified by chromatography on silica using a
Page 94
©ARKAT-USA, Inc.